An Italian study, conducted by a team of researchers from several Italian and Spanish universities and research centers under the supervision of CoEHAR experts, shows that antibodies induced by the anti-Covid-19 vaccine decrease faster in smokers
Tobacco harm reduction theories and their fundamental principles are questioned worldwide. New indicators specifically designed to establish the harm reduction potential of low risk tobacco products are examined by CoEHAR, with promising results
The REPLICA Project is proud to announce the third Harmonization meeting involving researchers and international partners. The two-day session is going to be held on May 26 and May 28 2021
What are the best practises the tobacco industry should follow to achieve a sustainable change through the innovation and regulation? This was the question that this year’s Global Tobacco and Nicotine Forum, GTFN 2020, focused on
Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.